Article ID Journal Published Year Pages File Type
3295679 Gastroenterology 2011 13 Pages PDF
Abstract
Deferasirox treatment for 3 or more years reversed or stabilized liver fibrosis in 83% of patients with iron-overloaded β-thalassemia. This therapeutic effect was independent of reduced concentration of liver iron (defined by the response criteria) or previous exposure to hepatitis C virus.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , , ,